Pharmaceutical Membrane Filtration Market

Global Pharmaceutical Membrane Filtration Market Size (2022 to 2027)

The global pharmaceutical membrane filtration market size was valued at USD 7.52 billion in 2022 and is expected to grow at a CAGR of 11%, worth USD 12.67 billion by 2027.

The micro-organism present during the purification and examination of medicinal preparations and the organisms present in air and water need vital membrane filtration process for a standard procedure. The membrane filtration is used to filter the drugs during the development of the drug projects. Membrane filters are used for different applications like capsule prefilters and so on.

MARKET DRIVERS:

Growing applications of membrane filters in biopharmaceutical and pharmaceutical industries are expected to drive the global pharmaceutical membrane filtration market growth.

Wide-scale adoption of the nanofiltration technology, the steadily growing biopharmaceutical industry, and rapid development in generics production is further expected to drive global pharmaceutical membrane filtration market growth. The countries' increasing economies are helping the manufacturers and key players expand their distribution networks and productivity in manufacturing capabilities that contribute to the growth of the pharmaceutical membrane filtration market.

The availability of advanced nanofiltration techniques and steadily increasing demand for single-use technologies are also expected to accelerate the global pharmaceutical membrane filtration market. The companies' adoption of effective and safe manufacturing practices contributes to the growth of the global pharmaceutical membrane market.

The emergence of advanced and innovative filtration techniques and systems is expected to create lucrative growth opportunities for key market players in the global pharmaceutical membrane filtration market during the forecast period. Increasing demand for biopharmaceutical products leads to an influx of investments for the research and development activities anticipated to boost the number of growth opportunities for the stakeholders operating in the pharmaceutical membrane filtration market.

Increasing economies of developed and developing nations like China, Brazil, India, Japan is leading to the expansion of the pharmaceutical industry in these regions and are supposed to offer more growth opportunities for the key players functioning in the market.

MARKET RESTRAINTS:

Operational costs of membrane filters are very high, resulting in the low adoption rate of these filters, which is a significant challenge for stakeholders and is limiting the growth of the pharmaceutical membrane filtration market. The reluctance of manufacturers to adopt membrane filters due to regular maintenance issues and complicated procedures such as membrane fouling is another major challenge to the key players in the market, which is restraining the growth of the pharmaceutical membrane filtration market.

Impact of COVID-19 on the global pharmaceutical membrane filtration market:

Covid-19 is a contagious disease that spreads easily from person to person. Covid-19 was first identified in Wuhan, China, in December 2019. World health organizations announced covid-19 as an emergence to the healthcare and declared certain guidelines. Various Biopharmaceutical firms around the world are working tirelessly to develop a vaccine for the novel coronavirus. To support the healthcare system, numerous government and private Equity acquisitions have been made. Biopharmaceutical companies use a variety of filtration techniques and materials to help the downstream method of vaccine production.

Numerous private Organizations have announced their financial assistance in research instruments and materials to Indonesia's Eijkman Institute for Molecular Biology to speed up vaccine production. In addition, the pandemic also provided ways for filtration companies to increase their production facilities. Sartorius revealed plans to open a consumer engagement center in North America to produce biopharmaceutical products in October 2020, and this center will also help with the manufacture and production of COVID-19 vaccines.  The effect of the coronavirus epidemic on pharmaceutical membrane filtration supply chains, production, and customer shipments has been manageable until now, with positive organic development. However, the market is expected to grow high in the coming years.

REPORT COVERAGE:

This research report on the global pharmaceutical membrane filtration market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2027.

Pharmaceutical Membrane Filtration Market - By Product:

• MCE
• Coated Cellulose Acetate
• Nylon
• PVDF Membrane

Pharmaceutical Membrane Filtration Market - By Technique:

• Microfiltration
• Ultra-Filtration
• Nanofiltration

Based on technique, the MCE membrane filters category is estimated to account for the biggest market share in 2016. This is majorly attributed to the high adoption rate of membrane filtration products. The microfiltration category is estimated to grow at the highest CAGR during the aforementioned forecast period. This can be attributed to the high rates of production of pharmaceutical products and drugs. The final product processing category is estimated to grow at the highest rate during the aforementioned forecast period.

Pharmaceutical Membrane Filtration Market – By Application:

• Final Product
• Raw Material

Pharmaceutical Membrane Filtration Market – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa

Presently, North America accounts for the largest market share while Asia Pacific has the highest CAGR. Growth in North America is basically due to the increasing instances of airborne diseases, which result in higher production generic drug production.

KEY MARKET PARTICIPANTS:

Some of the companies operating in the global pharmaceutical membrane filtration market covered in this report are Merck KGaA (Germany), General Healthcare Company (U.K.), Pall Corporation (U.S.), Sartorius Stedim Biotech Group (France), Alfa Laval (Sweden), Graver Technologies, LLC (U.S.), Koch Membrane Systems Inc. (U.S.), GEA Group (Germany) and Novasep (U.S.).

RECENT HAPPENINGS IN THIS MARKET:

• In July 2018, Pall Corporation allied with BioSciencesCorp to boost the manufacturing process. The key objectives of this collaboration are to provide cost-reducing business solutions and equipment for the manufacturers and enhanced technologies and support to the customers. 
• In 2019, a pharmaceutical plant developed an MBR system for producing UF-grade water. The system consists of EnviQ ultrafiltration membranes that separate the solid particles and remove organic waste from the water at high efficiency; these membranes also assist the operation in minimizing bio-fouling and even work efficiently in harsh conditions.